Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies

Authors:

Abstract
No abstract available
Funding Information
  • Aimmune Therapeutics
  • Genentech
  • National Peanut Board
  • Johnson and Johnson
  • Allergy Therapeutics
  • Merck
  • European Academy of Allergy and Clinical Immunology
  • Sanofi Genzyme
  • National Children's Research Centre
  • Agency for Healthcare Research and Quality (5K08HS024599-02)
  • National Institute of Allergy and Infectious Diseases

This publication has 28 references indexed in Scilit: